Switch to:
Also traded in: Brazil, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash-to-Debt 0.87
AET's Cash-to-Debt is ranked lower than
70% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.51 vs. AET: 0.87 )
Ranked among companies with meaningful Cash-to-Debt only.
AET' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.32  Med: 9.57 Max: 59.86
Current: 0.87
0.32
59.86
Equity-to-Asset 0.27
AET's Equity-to-Asset is ranked lower than
69% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.34 vs. AET: 0.27 )
Ranked among companies with meaningful Equity-to-Asset only.
AET' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.06  Med: 0.2 Max: 0.3
Current: 0.27
0.06
0.3
Debt-to-Equity 0.65
AET's Debt-to-Equity is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.55 vs. AET: 0.65 )
Ranked among companies with meaningful Debt-to-Equity only.
AET' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.09  Med: 0.22 Max: 1.24
Current: 0.65
0.09
1.24
Debt-to-EBITDA 2.57
AET's Debt-to-EBITDA is ranked lower than
68% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.05 vs. AET: 2.57 )
Ranked among companies with meaningful Debt-to-EBITDA only.
AET' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.99  Med: 1.54 Max: 3.92
Current: 2.57
0.99
3.92
Interest Coverage 6.78
AET's Interest Coverage is ranked lower than
88% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 12.39 vs. AET: 6.78 )
Ranked among companies with meaningful Interest Coverage only.
AET' s Interest Coverage Range Over the Past 10 Years
Min: 6.78  Med: 11.54 Max: 15.48
Current: 6.78
6.78
15.48
Piotroski F-Score: 4
Altman Z-Score: 2.30
Beneish M-Score: -2.32
WACC vs ROIC
4.93%
13.30%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 5.95
AET's Operating Margin % is ranked higher than
65% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 5.13 vs. AET: 5.95 )
Ranked among companies with meaningful Operating Margin % only.
AET' s Operating Margin % Range Over the Past 10 Years
Min: 5.47  Med: 7.76 Max: 10.2
Current: 5.95
5.47
10.2
Net Margin % 2.93
AET's Net Margin % is ranked lower than
58% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.24 vs. AET: 2.93 )
Ranked among companies with meaningful Net Margin % only.
AET' s Net Margin % Range Over the Past 10 Years
Min: 2.93  Med: 4.26 Max: 6.63
Current: 2.93
2.93
6.63
ROE % 11.05
AET's ROE % is ranked lower than
75% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.08 vs. AET: 11.05 )
Ranked among companies with meaningful ROE % only.
AET' s ROE % Range Over the Past 10 Years
Min: 11.05  Med: 15.65 Max: 19.85
Current: 11.05
11.05
19.85
ROA % 2.89
AET's ROA % is ranked lower than
70% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 4.31 vs. AET: 2.89 )
Ranked among companies with meaningful ROA % only.
AET' s ROA % Range Over the Past 10 Years
Min: 2.89  Med: 4.05 Max: 5.2
Current: 2.89
2.89
5.2
ROC (Joel Greenblatt) % 563.19
AET's ROC (Joel Greenblatt) % is ranked higher than
87% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 115.09 vs. AET: 563.19 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
AET' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 421.13  Med: 565.4 Max: 919.39
Current: 563.19
421.13
919.39
3-Year Revenue Growth Rate 10.60
AET's 3-Year Revenue Growth Rate is ranked higher than
57% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.60 vs. AET: 10.60 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
AET' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -15.7  Med: 5.3 Max: 22
Current: 10.6
-15.7
22
3-Year EBITDA Growth Rate 11.60
AET's 3-Year EBITDA Growth Rate is ranked higher than
50% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 11.60 vs. AET: 11.60 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
AET' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0  Med: 2.6 Max: 76.7
Current: 11.6
0
76.7
3-Year EPS without NRI Growth Rate 6.30
AET's 3-Year EPS without NRI Growth Rate is ranked lower than
53% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.40 vs. AET: 6.30 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
AET' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -13  Med: 6.4 Max: 63.9
Current: 6.3
-13
63.9
GuruFocus has detected 6 Warning Signs with Aetna Inc AET.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» AET's 30-Y Financials

Financials (Next Earnings Date: 2018-01-31)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

AET Guru Trades in Q4 2016

George Soros 31,000 sh (New)
David Swensen 2,240 sh (New)
Steven Cohen 125,469 sh (New)
Ray Dalio 189,000 sh (New)
John Burbank 69,424 sh (New)
Jana Partners 892,719 sh (New)
Lee Ainslie 2,229,816 sh (+41735.20%)
Chris Davis 3,937,198 sh (+161.73%)
Jim Simons 2,842,782 sh (+157.11%)
Joel Greenblatt 37,850 sh (+50.50%)
Diamond Hill Capital 1,547,498 sh (+43.54%)
Larry Robbins 5,194,064 sh (+0.28%)
Richard Pzena 155,248 sh (unchged)
Jeff Auxier 5,316 sh (unchged)
Jana Partners 2,100,000 sh (unchged)
John Buckingham 87,655 sh (-2.00%)
Paul Tudor Jones 9,411 sh (-3.08%)
Vanguard Health Care Fund 6,754,289 sh (-17.37%)
Jeremy Grantham 71,644 sh (-64.48%)
Pioneer Investments 90,499 sh (-92.66%)
David Dreman 343 sh (-96.26%)
» More
Q1 2017

AET Guru Trades in Q1 2017

Eaton Vance Worldwide Health Sciences Fund 191,137 sh (New)
Louis Moore Bacon 25,000 sh (+911.74%)
Steven Cohen 228,300 sh (+81.96%)
Paul Tudor Jones 16,335 sh (+73.57%)
Jana Partners 1,450,016 sh (+62.43%)
Joel Greenblatt 44,978 sh (+18.83%)
Jim Simons 3,111,482 sh (+9.45%)
Diamond Hill Capital 1,656,372 sh (+7.04%)
Chris Davis 4,163,857 sh (+5.76%)
David Dreman Sold Out
George Soros Sold Out
David Swensen Sold Out
John Burbank Sold Out
Jeff Auxier 5,307 sh (-0.17%)
Richard Pzena 154,946 sh (-0.19%)
Pioneer Investments 90,146 sh (-0.39%)
Larry Robbins 5,029,073 sh (-3.18%)
John Buckingham 82,287 sh (-6.12%)
Vanguard Health Care Fund 5,230,989 sh (-22.55%)
Ray Dalio 85,970 sh (-54.51%)
Lee Ainslie 987,480 sh (-55.71%)
Jeremy Grantham 24,877 sh (-65.28%)
» More
Q2 2017

AET Guru Trades in Q2 2017

Dodge & Cox 1,400 sh (New)
David Dreman 7,320 sh (New)
Richard Pzena 154,946 sh (unchged)
Jeff Auxier 5,307 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 191,137 sh (unchged)
Ray Dalio Sold Out
Jana Partners Sold Out
Louis Moore Bacon Sold Out
Paul Tudor Jones Sold Out
John Buckingham 81,952 sh (-0.41%)
Diamond Hill Capital 1,630,235 sh (-1.58%)
Vanguard Health Care Fund 5,101,289 sh (-2.48%)
Chris Davis 3,980,111 sh (-4.41%)
Jeremy Grantham 22,277 sh (-10.45%)
Pioneer Investments 78,035 sh (-13.43%)
Larry Robbins 3,310,469 sh (-34.17%)
Joel Greenblatt 28,625 sh (-36.36%)
Steven Cohen 128,600 sh (-43.67%)
Jim Simons 1,290,092 sh (-58.54%)
Lee Ainslie 11,470 sh (-98.84%)
» More
Q3 2017

AET Guru Trades in Q3 2017

Ray Dalio 11,904 sh (New)
Leon Cooperman 179,700 sh (New)
Paul Tudor Jones 13,663 sh (New)
George Soros 88,100 sh (New)
Caxton Associates 3,200 sh (New)
Steven Cohen 429,353 sh (+233.87%)
Joel Greenblatt 44,344 sh (+54.91%)
Lee Ainslie 14,020 sh (+22.23%)
Larry Robbins 3,794,484 sh (+14.62%)
Diamond Hill Capital 1,633,972 sh (+0.23%)
John Buckingham 82,109 sh (+0.19%)
Pioneer Investments 78,035 sh (unchged)
Jeff Auxier 5,307 sh (unchged)
Dodge & Cox 1,400 sh (unchged)
David Dreman 7,320 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 191,137 sh (unchged)
Richard Pzena Sold Out
Chris Davis 3,824,917 sh (-3.90%)
Vanguard Health Care Fund 4,646,623 sh (-8.91%)
Jim Simons 605,490 sh (-53.07%)
Jeremy Grantham 10,177 sh (-54.32%)
» More
» Details

Insider Trades

Latest Guru Trades with AET

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Vanguard Health Care Fund 2017-09-30 Reduce -8.91%0.15%$151.98 - $163.21 $ 173.2011%4,646,623
Chris Davis 2017-09-30 Reduce -3.90%0.1%$151.98 - $163.21 $ 173.2011%3,824,917
Leon Cooperman 2017-09-30 New Buy1.11%$151.98 - $163.21 $ 173.2011%179,700
George Soros 2017-09-30 New Buy0.42%$151.98 - $163.21 $ 173.2011%88,100
Joel Greenblatt 2017-09-30 Add 54.91%0.04%$151.98 - $163.21 $ 173.2011%44,344
Richard Pzena 2017-09-30 Sold Out 0.13%$151.98 - $163.21 $ 173.2011%0
Vanguard Health Care Fund 2017-06-30 Reduce -2.48%0.04%$127.28 - $152.98 $ 173.2023%5,101,289
Chris Davis 2017-06-30 Reduce -4.41%0.1%$127.28 - $152.98 $ 173.2023%3,980,111
Joel Greenblatt 2017-06-30 Reduce -36.36%0.03%$127.28 - $152.98 $ 173.2023%28,625
David Dreman 2017-06-30 New Buy0.61%$127.28 - $152.98 $ 173.2023%7,320
Dodge & Cox 2017-06-30 New Buy$127.28 - $152.98 $ 173.2023%1,400
Vanguard Health Care Fund 2017-03-31 Reduce -22.55%0.45%$116.71 - $134.11 $ 173.2038%5,230,989
Chris Davis 2017-03-31 Add 5.76%0.12%$116.71 - $134.11 $ 173.2038%4,163,857
Richard Pzena 2017-03-31 Reduce -0.19%$116.71 - $134.11 $ 173.2038%154,946
Joel Greenblatt 2017-03-31 Add 18.83%0.01%$116.71 - $134.11 $ 173.2038%44,978
George Soros 2017-03-31 Sold Out 0.13%$116.71 - $134.11 $ 173.2038%0
David Swensen 2017-03-31 Sold Out 0.05%$116.71 - $134.11 $ 173.2038%0
David Dreman 2017-03-31 Sold Out 0.02%$116.71 - $134.11 $ 173.2038%0
Vanguard Health Care Fund 2016-12-31 Reduce -17.37%0.35%$105.2 - $134.9 $ 173.2045%6,754,289
Chris Davis 2016-12-31 Add 161.73%1.32%$105.2 - $134.9 $ 173.2045%3,937,198
Joel Greenblatt 2016-12-31 Add 50.50%0.02%$105.2 - $134.9 $ 173.2045%37,850
George Soros 2016-12-31 New Buy0.13%$105.2 - $134.9 $ 173.2045%31,000
David Swensen 2016-12-31 New Buy0.05%$105.2 - $134.9 $ 173.2045%2,240
David Dreman 2016-12-31 Reduce -96.26%0.62%$105.2 - $134.9 $ 173.2045%343
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Plans » Health Care Plans    NAICS: 524114    SIC: 6324
Compare:NYSE:ANTM, NYSE:CI, NYSE:HUM, NAS:ESRX, NYSE:CNC, NYSE:WCG, NYSE:MOH, BSP:QUAL3, BSP:ODPV3, NAS:MGLN, XPAR:GDS, OSTO:MCOV B, NAS:HIIQ, ATH:IATR, ASX:ONT, MIL:HI, OTCPK:HFRN, OSTO:FEEL, OTCPK:OPRX, OTCPK:WCUI » details
Traded in other countries:AETB34.Brazil, HE8.Germany,
Headquarter Location:USA
Aetna Inc is a diversified health care benefits company. The company offers traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, and behavioral health.

Aetna is one of the largest managed-care organizations in the U.S., with over 22 million medical members. This member count will increase significantly if the firm is able to close the Humana acquisition. The firm provides health insurance services to its members through products that encompass every major insurance market--individual, group, and government sponsored. Aetna has a large nationwide operation and competes in most major U.S. geographies.

Top Ranked Articles about Aetna Inc

Leon Cooperman Starts 4 Positions in 3rd Quarter Hedge fund guru reports quarterly portfolio
Omega Advisors fund manager Leon Cooperman (Trades, Portfolio) combines his macro view and fundamental valuation in his investing strategy. During the third quarter, Cooperman initiated positions in DowDuPont Inc. (NYSE:DWDP), Aetna Inc. (NYSE:AET), Expedia Inc. (NASDAQ:EXPE) and Adobe Systems Inc. (NASDAQ:ADBE). Read more...
Recent Analysis Shows Spirit Realty, Interpublic Group, Aetna, VEREIT, LendingClub, and Juniper Market Influences – Renewed Outlook, Key Drivers of Growth
Vanguard Health Care Fund Trims Positions in Vertex, Regeneron, Illumina Fund's largest 3rd-quarter sales
Founded in 1984, the Vanguard Health Care Fund (Trades, Portfolio) is managed by Jean Hynes. During the third quarter, the fund reduced its positions in the following stocks: Read more...
U.S. News and Aetna Foundation Unveil Healthiest Communities at National Healthcare of Tomorrow Forum
David Dreman’s Top 5 Health Care Buys for the 2nd Quarter Guru takes new positions in stocks he previously sold
Dreman Value Management founder David Dreman (Trades, Portfolio) established 210 new positions in the second quarter, of which 20 were in health care companies. His top five health care buys were Aetna Inc. (NYSE:AET), Zimmer Biomet Holdings Inc. (NYSE:ZBH), Amgen Inc. (NASDAQ:AMGN), Biogen Inc. (NASDAQ:BIIB) and Cardinal Health Inc. (NYSE:CAH). Read more...
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Aetna Inc. (AET)
Aetna Announces A Brighter Experience For All Dental Members
David Swensen Sells 5 Holdings, Buys 2 Others An overview of the guru's 1st-quarter trades
David Swensen (Trades, Portfolio) is responsible for managing Yale University's endowment assets and investment funds. He manages a portfolio of six stocks worth $495 million. During the first quarter, the guru traded shares in the following stocks: Read more...
Edward Owens Buys Abbott Labs, Sells Allergan, Amgen, Aetna Vanguard Health Care Fund's largest 1st-quarter trades
Edward Owens has managed the Vanguard Health Care Fund (Trades, Portfolio) since its inception in May 1984. It invests primarily in health care companies. Read more...
Insiders Roundup: Facebook, General Electric, Aetna The largest insider trades of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “March 2017” and All Insider Sales to “$5,000,000+.” Read more...

Ratios

vs
industry
vs
history
PE Ratio 32.06
AET's PE Ratio is ranked lower than
90% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 19.90 vs. AET: 32.06 )
Ranked among companies with meaningful PE Ratio only.
AET' s PE Ratio Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 32.06
5.42
45.35
Forward PE Ratio 17.39
AET's Forward PE Ratio is ranked higher than
55% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.85 vs. AET: 17.39 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 32.06
AET's PE Ratio without NRI is ranked lower than
86% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 20.71 vs. AET: 32.06 )
Ranked among companies with meaningful PE Ratio without NRI only.
AET' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.42  Med: 12.66 Max: 45.35
Current: 32.06
5.42
45.35
Price-to-Owner-Earnings 148.17
AET's Price-to-Owner-Earnings is ranked lower than
94% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.97 vs. AET: 148.17 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
AET' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.35  Med: 12.49 Max: 151.4
Current: 148.17
5.35
151.4
PB Ratio 3.63
AET's PB Ratio is ranked lower than
64% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 2.89 vs. AET: 3.63 )
Ranked among companies with meaningful PB Ratio only.
AET' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.83 Max: 3.7
Current: 3.63
0.88
3.7
PS Ratio 0.97
AET's PS Ratio is ranked lower than
60% of the 25 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.58 vs. AET: 0.97 )
Ranked among companies with meaningful PS Ratio only.
AET' s PS Ratio Range Over the Past 10 Years
Min: 0.29  Med: 0.54 Max: 1.13
Current: 0.97
0.29
1.13
Price-to-Free-Cash-Flow 58.40
AET's Price-to-Free-Cash-Flow is ranked lower than
83% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.51 vs. AET: 58.40 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
AET' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.49  Med: 11.45 Max: 59.67
Current: 58.4
4.49
59.67
Price-to-Operating-Cash-Flow 42.59
AET's Price-to-Operating-Cash-Flow is ranked lower than
80% of the 20 Companies
in the Global Health Care Plans industry.

( Industry Median: 10.80 vs. AET: 42.59 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
AET' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.68  Med: 9.69 Max: 43.51
Current: 42.59
3.68
43.51
EV-to-EBIT 17.70
AET's EV-to-EBIT is ranked lower than
71% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: 13.46 vs. AET: 17.70 )
Ranked among companies with meaningful EV-to-EBIT only.
AET' s EV-to-EBIT Range Over the Past 10 Years
Min: 3.9  Med: 7.6 Max: 19.1
Current: 17.7
3.9
19.1
EV-to-EBITDA 14.73
AET's EV-to-EBITDA is ranked lower than
78% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 9.98 vs. AET: 14.73 )
Ranked among companies with meaningful EV-to-EBITDA only.
AET' s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.5  Med: 6.6 Max: 15.4
Current: 14.73
3.5
15.4
EV-to-Revenue 0.95
AET's EV-to-Revenue is ranked lower than
54% of the 26 Companies
in the Global Health Care Plans industry.

( Industry Median: 0.83 vs. AET: 0.95 )
Ranked among companies with meaningful EV-to-Revenue only.
AET' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 0.6 Max: 1.1
Current: 0.95
0.3
1.1
PEG Ratio 3.03
AET's PEG Ratio is ranked lower than
69% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.73 vs. AET: 3.03 )
Ranked among companies with meaningful PEG Ratio only.
AET' s PEG Ratio Range Over the Past 10 Years
Min: 0.36  Med: 0.98 Max: 6.51
Current: 3.03
0.36
6.51
Shiller PE Ratio 32.37
AET's Shiller PE Ratio is ranked lower than
62% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 25.17 vs. AET: 32.37 )
Ranked among companies with meaningful Shiller PE Ratio only.
AET' s Shiller PE Ratio Range Over the Past 10 Years
Min: 10.39  Med: 19.44 Max: 47.23
Current: 32.37
10.39
47.23
Current Ratio 0.84
AET's Current Ratio is ranked lower than
74% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.16 vs. AET: 0.84 )
Ranked among companies with meaningful Current Ratio only.
AET' s Current Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.87 Max: 2.78
Current: 0.84
0.54
2.78
Quick Ratio 0.84
AET's Quick Ratio is ranked lower than
70% of the 23 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.16 vs. AET: 0.84 )
Ranked among companies with meaningful Quick Ratio only.
AET' s Quick Ratio Range Over the Past 10 Years
Min: 0.54  Med: 0.87 Max: 2.78
Current: 0.84
0.54
2.78
Days Sales Outstanding 29.51
AET's Days Sales Outstanding is ranked lower than
56% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 32.83 vs. AET: 29.51 )
Ranked among companies with meaningful Days Sales Outstanding only.
AET' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.34  Med: 24.57 Max: 29.51
Current: 29.51
16.34
29.51
Days Payable 49.65
AET's Days Payable is ranked higher than
54% of the 13 Companies
in the Global Health Care Plans industry.

( Industry Median: 49.78 vs. AET: 49.65 )
Ranked among companies with meaningful Days Payable only.
AET' s Days Payable Range Over the Past 10 Years
Min: 38.83  Med: 47.09 Max: 52.51
Current: 49.65
38.83
52.51

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.00
AET's Dividend Yield % is ranked lower than
83% of the 29 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.41 vs. AET: 1.00 )
Ranked among companies with meaningful Dividend Yield % only.
AET' s Dividend Yield % Range Over the Past 10 Years
Min: 0.07  Med: 0.82 Max: 1.77
Current: 1
0.07
1.77
Dividend Payout Ratio 0.28
AET's Dividend Payout Ratio is ranked higher than
80% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 9999.00 vs. AET: 0.28 )
Ranked among companies with meaningful Dividend Payout Ratio only.
AET' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.01  Med: 0.12 Max: 0.28
Current: 0.28
0.01
0.28
3-Year Dividend Growth Rate 7.70
AET's 3-Year Dividend Growth Rate is ranked lower than
63% of the 8 Companies
in the Global Health Care Plans industry.

( Industry Median: 14.90 vs. AET: 7.70 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
AET' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 0 Max: 171.4
Current: 7.7
0
171.4
Forward Dividend Yield % 1.14
AET's Forward Dividend Yield % is ranked lower than
81% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.53 vs. AET: 1.14 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 2.10
AET's 5-Year Yield-on-Cost % is ranked lower than
68% of the 40 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.99 vs. AET: 2.10 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
AET' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.15  Med: 1.72 Max: 3.72
Current: 2.1
0.15
3.72
3-Year Average Share Buyback Ratio 1.00
AET's 3-Year Average Share Buyback Ratio is ranked higher than
62% of the 21 Companies
in the Global Health Care Plans industry.

( Industry Median: -0.30 vs. AET: 1.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
AET' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -10.2  Med: 0.6 Max: 8.8
Current: 1
-10.2
8.8

Valuation & Return

vs
industry
vs
history
Price-to-Tangible-Book 15.58
AET's Price-to-Tangible-Book is ranked lower than
74% of the 19 Companies
in the Global Health Care Plans industry.

( Industry Median: 7.70 vs. AET: 15.58 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
AET' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.55  Med: 3.67 Max: 23.42
Current: 15.58
0.55
23.42
Price-to-Intrinsic-Value-Projected-FCF 1.30
AET's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
50% of the 18 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.19 vs. AET: 1.30 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
AET' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.23  Med: 0.7 Max: 2
Current: 1.3
0.23
2
Price-to-Intrinsic-Value-DCF (Earnings Based) 2.23
AET's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
100% of the 9 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.51 vs. AET: 2.23 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
AET' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.39  Med: 0.97 Max: 2.76
Current: 2.23
0.39
2.76
Price-to-Median-PS-Value 1.78
AET's Price-to-Median-PS-Value is ranked lower than
79% of the 24 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.10 vs. AET: 1.78 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
AET' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.85 Max: 2.35
Current: 1.78
0.29
2.35
Price-to-Peter-Lynch-Fair-Value 4.92
AET's Price-to-Peter-Lynch-Fair-Value is ranked lower than
100% of the 11 Companies
in the Global Health Care Plans industry.

( Industry Median: 1.62 vs. AET: 4.92 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
AET' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.19  Med: 0.84 Max: 5.14
Current: 4.92
0.19
5.14
Price-to-Graham-Number 4.71
AET's Price-to-Graham-Number is ranked lower than
75% of the 12 Companies
in the Global Health Care Plans industry.

( Industry Median: 3.10 vs. AET: 4.71 )
Ranked among companies with meaningful Price-to-Graham-Number only.
AET' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.36  Med: 1.53 Max: 5.77
Current: 4.71
0.36
5.77
Earnings Yield (Greenblatt) % 5.65
AET's Earnings Yield (Greenblatt) % is ranked lower than
56% of the 27 Companies
in the Global Health Care Plans industry.

( Industry Median: 6.07 vs. AET: 5.65 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
AET' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 5.2  Med: 13.2 Max: 25.4
Current: 5.65
5.2
25.4
Forward Rate of Return (Yacktman) % 10.90
AET's Forward Rate of Return (Yacktman) % is ranked lower than
73% of the 15 Companies
in the Global Health Care Plans industry.

( Industry Median: 15.68 vs. AET: 10.90 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
AET' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6  Med: 19.6 Max: 37.2
Current: 10.9
6
37.2

More Statistics

Revenue (TTM) (Mil) $61,410.00
EPS (TTM) $ 5.40
Beta0.53
Short Percentage of Float0.79%
52-Week Range $116.04 - 184.98
Shares Outstanding (Mil)326.10

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 60,546 60,707 64,354
EPS ($) 9.59 9.83 11.09
EPS without NRI ($) 9.59 9.83 11.09
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.27%
Dividends per Share ($) 1.34 1.34 1.50

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAN
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyY
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}